Iowa City, IA, United States of America

Michael K Schultz

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Michael K Schultz: Innovator in Cancer Therapy and Chelation Methods

Introduction

Michael K Schultz is a prominent inventor based in Iowa City, IA, known for his significant contributions to the fields of cancer therapy and chelation methods. With a total of 10 patents to his name, Schultz has made remarkable strides in improving therapeutic techniques for cancer treatment.

Latest Patents

Among his latest patents is a structural optimization method aimed at enhancing the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers. This invention provides a carcinoma-targeting conjugate that is designed to improve treatment efficacy. Another notable patent involves compositions for chelating metals at low temperatures. This method outlines a chelating reaction that includes contacting a divalent metal with a specific compound, resulting in a chelated composition formed at temperatures below about 40° C.

Career Highlights

Throughout his career, Michael K Schultz has worked with esteemed institutions such as the University of Iowa Research Foundation and the University of Michigan. His work has been pivotal in advancing research and development in his areas of expertise.

Collaborations

Schultz has collaborated with notable colleagues, including Somya Kapoor and Douglas R Spitz, Jr. These partnerships have contributed to the innovative research and development of his patented technologies.

Conclusion

Michael K Schultz stands out as a key figure in the innovation of cancer therapies and chelation methods. His extensive patent portfolio reflects his dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…